The Polish pharmaceutical market. Its condition and growth prospects until 2011 in the opinion of the largest pharmaceutical companies
Marcin Rudnicki, Partner, Head of the Pharmaceuticals Group, KPMG emphasises: „Pharmaceutical companies expect continued growth of the market. Over half of companies surveyed plan to increase investments in employee development and production infrastructure in the next 12 months.” He also points out that “More than 60% of the surveyed companies described the current market situation as good or very good –a steep 40% of the surveyed companies plan to introduce 3 to 10 new drugs by the end of 2009.”
Monika Bartoszewicz, Partner, Audit Department, KPMG adds: „It appears that the pharmaceutical sector has managed to find a solution to achieve growth during the times of economic slowdown. In 2009, the value of the pharmaceutical market in Poland will exceed PLN 25bn, which shows a significant improvement over the figure for 2008.
On-line pharmacies will be the fastest growing distribution channel – a whopping 80% of the companies surveyed predict that distribution through this channel will develop faster than the pharmacy sales market as a whole”.
Monika Stefanczyk, Head Pharmaceutical Market Analyst, PMR, comments:
„In the opinion of the companies operating in the pharmaceutical market, unfavourable legal regulations, including the Regulation on pharmaceutical advertising of 2008 and insufficient transparency of decisions regarding pharmaceutical reimbursement, are among the largest barriers to the growth of the pharmaceutical market, which is a consequence of the failure to implement the EU laws. Dietary supplement producers voice concerns about by the approaching end of the transitional period for the so-called borderline products. It should be noted that these impediments were not strong enough to block the market’s growth in 2009 since a high number of infections was a decisive factor influencing growth of the pharmaceutical market”.
Some of the conclusions of the report:
• Polish companies provided more favourable assessments of the market situation compared to companies with a substantial foreign equity stake. For instance, the “good” assessments were given by two-thirds of mostly Polish companies and less than 50% of companies with a foreign-equity shareholding.
• Assessment of the current situation of the market also varies depending on the principal business segment. Enterprises operating mostly in the dietary supplement segment provided significantly more upbeat assessments of the present market situation.
• Most frequently mentioned reasons provided by respondents as justification of their positive assessment of the current market situation (54%) and the stability of the sector (52%).
• According to respondents of the survey, the factors which will have the largest influence on the development of activities in the Polish pharmaceutical sectors primarily included introduction of new products to the market (30%), overall increase in the wealth of the Polish society (14%) and access to reimbursement (12%).
• Nearly three-quarters of respondents anticipated that new categories of medicines would appear on the market in the next two years. The new preparations used to treat cancer stood the greatest chance of being introduced to the market (nearly half of responses).
• In terms of regulatory issues, pharmaceutical companies are particularly constrained by restrictions on advertising and promotion of drugs set forth on the Regulation on pharmaceutical advertising of November 2008 and the lack of transparent policies with regard to drug reimbursement, which results, for instance, in unfair treatment for manufacturers of innovative and generic products.
Commenting on the projected impact of legal changes, including in particular the most controversial of them concerning fixed margins on reimbursed drugs, Monika Przygodzka, Senior Tax Manager, Tax Advisory Department, KPMG, notes that:
„The maximum fixed margin on subsidised drugs (in both wholesale and pharmacy trading) will not be freely reduced by wholesalers or pharmacies, as has been done hitherto, and the subsidised pharmaceuticals will have the same prices in all pharmacies – in the opinion of companies surveyed, this change will have an adverse effect on drug distributors but it will be rather beneficial to patients.”
“The 2008 year was one of the best for the pharmaceutical industry in the last decade, in part because of high GDP growth and related increases in the purchasing power of Polish consumers. Non-refunded OTC products, with dietary supplements at the helm, drove market growth”, says Karol Kolt, President of PMR’s Management Board. Mr Kolt also adds: „in 2008 OTC products already represented 34% of the pharmacy market in Poland, whereas in 2005 they accounted for around 30%. Close to half of 2008 market value was, however, generated by sales of prescription preparations subject to reimbursement”.
The main areas covered in the report:
1. The size of the pharmaceutical market in Poland and its growth prospects in the coming years
2. Barriers to the growth of the pharmaceutical market
3. Impact of the planned legal changes on the pharmaceutical sector
4. Development of pharmaceutical distribution channels
5. The financial standing of pharmaceutical companies
Full version of the report is available at pmrcorporate.com and kpmg.pl.
PMR is a British-American company providing high-quality market information and services to businesses interested in Central and Eastern Europe and other developing markets. PMR's key areas of operation include business publications (PMR Publications), consultancy services (PMR Consulting) and market research (PMR Research).
With over 14 years of experience, top quality products and services and top-ranked websites, PMR is one of the largest companies of its type in Central and Eastern Europe.
ul. Supniewskiego 9, 31-527 Krakow, Poland
tel. /48/ 12 618 90 00, fax /48/ 12 618 90 08
Karolina Kaminska - Marketing Department
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Polish pharmaceutical market. Its condition and growth prospects until 2011 in the opinion of the largest pharmaceutical companies here
News-ID: 111774 • Views: 791
More Releases from PMR Publications
Russian retail market recovered after the economic slowdown
Retail markets in all Russian Federal Districts increased in 2010 by total $80bn In 2010, Russian retail market recovered after the economic slowdown observed in the previous year and increased by 12.6% to RUB 16.4tr ($541bn). However, the latest PMR report „Retail in Russia 2011 – Regional focus. Market analysis and development forecasts for 2011-2013” shows that particular regional retail markets still reveal differences in their development due to their unique
Construction output in Poland up by 10% in 2011
The forthcoming year 2011 can be a breakthrough year for the construction industry in terms of construction output. Provided that the winter weather conditions are relatively favourable, the 2011 average annual growth rate can be up to 10%, driven by large civil engineering projects and major improvement in the building construction sector. According to a report prepared by research company PMR, which is entitled "Construction sector in Poland, H2 2010 -
Russian construction industry recovers after the downturn
For the first time this decade, in 2009 the construction industry in Russia, which was severely affected by the global economic downturn, shrank in comparison with the preceding year. In the current year, a recovery has begun, prompted by the numerous projects supported or directly funded by the government. In the next few months, growth in the construction industry will be driven by the civil engineering and residential construction subdivisions
Retail market in Russia to grow by almost 10% in 2010
The growth rate of the Russian retail sector dropped severely last year due to worsening economic conditions, weakening purchasing power growth and the depreciating rouble. As a result, the retail market's value increased by only 5% in 2009 after several years of roughly 25% annual growth. Nevertheless, the situation has improved this year, and the retail market is expected to once again reach double-digit growth rates in subsequent years. According to
More Releases for Polish
Nail Polish Market Research Report 2019
Abstract: Nail Polish Market report focuses on Nail Polish volume and value at global level, regional level and company level. From a global perspective, Nail Polish Market report represents overall Nail Polish market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. Download FREE Sample of this Report @ https://www.24chemicalresearch.com/download-sample/16698/global-nail-polish-2019-269 The global Nail Polish market is valued at 9190 million
THE POLISH POTTERY SHOPPE ANNOUNCES NEW ARRIVALS
SPRINGFIELD, MISSOURI-FEBRUARY 13, 2019- The Polish Pottery Shoppe in Springfield, MO is excited to announce new products in stock direct from Boleslawiec, Poland. The new shipment contains over 2,000 pieces of handmade, hand-painted designs. Opened in 2014, The Polish Pottery Shoppe has catered to customers that enjoy adding flair to their home through accent and functional pottery from Poland. The unique style and designs are some of the most beautiful
Global Nail Enamel Sales Market Top Manufacturers Light Nail Polish, Transparent …
Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Nail Enamel for these regions, from 2013 to 2025 (forecast), covering United States China Europe Japan Southeast Asia India Request for discount @ https://www.researchtrades.com/discount/1547955 Global Nail Enamel market competition by top manufacturers/players, with Nail Enamel sales volume, Price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including OPI Bobbi Brown Essie Revlon Japan Glaze Dior ORLY COSMAY CND Cover Girl Loreal Paris Sally
60% of Polish SMEs use IT services
Approx. 60% of small and medium sized enterprises use IT services in Poland. Some 30% of SMEs declare to employ people responsible for IT. The number of portable computers used by SMEs has been growing. On average, there are five such computers per one SME. The proportion of companies which use EU funds to finance ICT development has gone down over the last two years. Use of IT services According to the
Excellent Results for Polish B2C E-Commerce
In its latest “Poland B2C E-Commerce Report 2011” Hamburg-based market research firm yStats.com presents comprehensive data on trends, revenue figures, market shares and competitors regarding B2C E-Commerce as well as internet users and online shoppers in Poland. In 2010, as many as 24 million people used the internet in Poland, which is more than half of the entire population. In line with this trend, Polish B2C E-Commerce has recorded double digit
Polish VoIP market 2010
Over the past two years, falling fixed telephony prices and the prominence of fixed mobile substitution have not managed to hinder the development of internet telephony. This was particularly notable in small and medium enterprises segment, where VoIP technology is used most because it is easy to integrate VoIP telephony with IT systems alongside the dropping prices. On the other hand, growth in the individual clients segment was most visible